CSIMarket


Thorne Healthtech Inc   (NASDAQ: THRN)
Other Ticker:  
 

Thorne Healthtech Inc

THRN's Fundamental analysis








Looking into Thorne Healthtech Inc growth rates, revenue grew by 29.69 % in the second quarter of 2023 from the same quarter a year ago. Ranking at No. 669

Major Pharmaceutical Preparations industry recorded deterioration of revenues by -8.1 %

Thorne Healthtech Inc realized net income compared to net loss a year ago in second quarter of 2023

More on THRN's Growth


Thorne Healthtech Inc
current PE on trailing twelve month basis is above Major Pharmaceutical Preparations industry average.

Thorne Healthtech Inc PEG ratio is at 0.33 Thorne Healthtech Inc realized cash reduction of $ -0.01 per share in trailing twelve-month period.
Company
27.51
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 2.14.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.87.


More on THRN's Valuation
 
 Total Debt (Millions $) 15
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ 1,267,068
 Net Income/Employee (TTM) $ 97,966
 Receivable Turnover (TTM) 14.18
 Tangible Book Value (Per Share $) 2.23

Thorne Healthtech Inc
current PE on trailing twelve month basis is above Major Pharmaceutical Preparations industry average.

Thorne Healthtech Inc PEG ratio is at 0.33 Thorne Healthtech Inc realized cash outflow of $ -0.01per share in trailing twelve-month period.
Company
27.51
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 2.14.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.87.

Thorne Healthtech Inc Price to Book Ratio is at 3.54 lower than Industry Avg. of 39.17. and higher than S&P 500 Avg. of 0.02

More on THRN's Valuation

  Market Capitalization (Millions $) 549
  Shares Outstanding (Millions) 54
  Employees 202
  Revenues (TTM) (Millions $) 256
  Net Income (TTM) (Millions $) 20
  Cash Flow (TTM) (Millions $) 0
  Capital Exp. (TTM) (Millions $) -39
  Total Debt (Millions $) 15
  Dividend TTM ($) 0 $
  Dividend Yield TTM (%) -
  Revenue/Employee (TTM) $ 1,267,068
  Net Income/Employee(TTM) $ 97,966
  Receivable Turnover Ratio (TTM) 14.18
  Tangible Book Value (Per Share $) 2.23

  Market Capitalization (Millions $) 549
  Shares Outstanding (Millions) 54
  Employees 202
  Revenues (TTM) (Millions $) 256
  Net Income (TTM) (Millions $) 20
  Cash Flow (TTM) (Millions $) 0
  Capital Exp. (TTM) (Millions $) -39


    THRN's Profitability Comparisons
Thorne Healthtech Inc achieved increase in profitability, due to increase in demand and cost control. Operating Margin grew in second quarter of 2023 to 9.11 %.

Thorne Healthtech Inc net profit margin of 5.96 % is currently ranking no. 52 in Major Pharmaceutical Preparations industry, ranking no. 139 in Healthcare sector and number 1807 in S&P 500.





  Ratio
   Capital Ratio (MRQ) 2.41
  Total Debt to Equity (MRQ) 0.1
  Tangible Leverage Ratio (MRQ) 1.07
  Asset Turnover Ratio (TTM) 1.19
  Inventory Turnover Ratio (TTM) 2.03



Thorne Healthtech Inc achieved increase in profitability, due to increase in demand and cost control. Operating Margin grew in second quarter of 2023 to 9.11 %.

Thorne Healthtech Inc net profit margin of 5.96 % is currently ranking no. 52 in Major Pharmaceutical Preparations industry, ranking no. 139 in Healthcare sector and number 1807 in S&P 500.

More on THRN's Key Ratios





Help

About us

Terms of Use

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2025 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.